COMPANY

NeurOptics

HQ: Irvine, CA source · neuroptics.com ↗ · West Coast

Keywords: research tools depression Opioid-Induced Respiratory Depression Postoperative Complications (Cardiopulmonary) Respiratory Complications Due to Anesthesia Infrared Pupillometry

Location: Irvine, CA · source · Oct 14, 2026

Profile checked Oct 10, 2026

1Trials (company is sponsor)3NIH grants

Timeline

May 4, 2026 Trial start —: Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Depression in Children Undergoing Tonsillectomy source ↗

Upcoming milestones

Apr 30, 2027 (ESTIMATED) · · Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Depression in Children Undergoing Tonsillectomy · NCT07573150

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT07573150	Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Depression in Children Undergoing Tonsillectomy	Not listed	Recruiting	May 4, 2026	Apr 30, 2027 (estimated)

NIH awards 3

Annual award amounts. Total $2.7M.

Jul 1, 2024 NIH award 5R44DA055407-03 FY2024: $1,092,027 awarded for that fiscal year; activity R44 (SBIR); PI OLIVER, JEFFREY WADE; recipient as written: NEUROPTICS, INC., IRVINE, CA. Development and Commercialization of a pupi source ↗
Jun 30, 2023 NIH award 4R44DA055407-02 FY2023: $1,271,838 awarded for that fiscal year; activity R44 (SBIR); PI OLIVER, JEFFREY WADE; recipient as written: NEUROPTICS, INC., IRVINE, CA. Development and Commercialization of a pupi source ↗
Jun 17, 2022 NIH award 1R44DA055407-01 FY2022: $319,082 awarded for that fiscal year; activity R44 (SBIR); PI OLIVER, JEFFREY WADE; recipient as written: NEUROPTICS, INC., IRVINE, CA. Development and Commercialization of a pupill source ↗